Immuno-oncology
- HMX
Group Enrollment Option A program that is a popular choice for organizations and institutions to purchase in bulk.
Learn how the immune system is being harnessed to improve cancer treatment.
- Online; Instructor-Paced
$1,025
Multi-course bundle pricing is also available across enrollment periods.
Certificate
Earn a Certificate of Completion upon successfully completing all coursework.
10 Weeks, 1-2 Hours/Week
Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge and how carefully you take notes.
- Online; Instructor-Paced
$1,025
Multi-course bundle pricing is also available across enrollment periods.
Certificate
Earn a Certificate of Completion upon successfully completing all coursework.
10 Weeks, 1-2 Hours/Week
Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge and how carefully you take notes.
On This Page
Overview
Advances in our knowledge of the immune system are changing the ways in which we treat various types of cancer. Understanding how immune cells recognize and kill cancer cells, and what we can do to enhance their ability to fight cancer, is important for anyone working to develop new cancer treatments or apply them in the clinic.
In this advanced HMX course, you will explore the interactions between cancer and the immune system. Through engaging, interactive lessons, you will learn the potential for harnessing the immune system to treat cancer, providing insights into innovative therapies such as immune checkpoint blockade, CAR T cell therapies, and tumor vaccines. With the help of real-world examples, you will gain a strong understanding of immuno-oncology that provides context for learning about future developments in this field.
Learning Objectives
- Understand the basics of tumor immunology
- Get an inside look at novel immunotherapies including checkpoint blockade and CAR T cell therapy
- See how advanced knowledge of the immune system is impacting patient care
Who Should Participate
Scientists in immunology or cancer-related research; clinicians or other medical professionals; health care industry and research professionals
Overview
Advances in our knowledge of the immune system are changing the ways in which we treat various types of cancer. Understanding how immune cells recognize and kill cancer cells, and what we can do to enhance their ability to fight cancer, is important for anyone working to develop new cancer treatments or apply them in the clinic.
In this advanced HMX course, you will explore the interactions between cancer and the immune system. Through engaging, interactive lessons, you will learn the potential for harnessing the immune system to treat cancer, providing insights into innovative therapies such as immune checkpoint blockade, CAR T cell therapies, and tumor vaccines. With the help of real-world examples, you will gain a strong understanding of immuno-oncology that provides context for learning about future developments in this field.
Learning Objectives
- Understand the basics of tumor immunology
- Get an inside look at novel immunotherapies including checkpoint blockade and CAR T cell therapy
- See how advanced knowledge of the immune system is impacting patient care
Who Should Participate
Scientists in immunology or cancer-related research; clinicians or other medical professionals; health care industry and research professionals
Questions?
Have questions about HMX courses, enrollment, or learning options? Contact our team by email—we’re happy to assist.
About the Course
HMX online courses bring complex material to life through engaging biomedical visualizations, clinical applications, and true-to-life scenarios paired with lectures from Harvard Medical School faculty and leading experts.
Who Should Enroll
This advanced course is appropriate for scientists in immunology or cancer-related research looking to gain clinical insights from both patient and physician perspectives on treating cancer using immunological approaches; clinicians or other medical professionals seeking detailed mechanistic explanations of the immune response to cancer, in addition to a comprehensive overview of immunological treatment strategies; health care industry and research professionals who are eager to develop a solid understanding of the fundamental aspects of the immune system in the context of cancer, balanced with in-depth discussion of clinical applications.
Course Format
Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge, how carefully you take notes, and how seriously you take the assessments. Lessons from the courses are released toward the beginning of the course session and remain available until the courses end, so you can work at your own pace. There is a final exam at the end of each course that can be taken at any time during the multi-week final exam period. The flexible course format makes this an ideal choice for working professionals.
Group Enrollments
HMX courses are ideal for organizations looking to train teams or larger groups. Group pricing is available, making it a cost-effective investment in team development.
Faculty
Andrew Lichtman
MD, PhD
- Professor of Pathology, Harvard Medical School
- Pathologist, Brigham and Women's Hospital
Shiv Pillai
MD, PhD
- Professor of Medicine and Health Sciences and Technology, Harvard Medical School
Andrew Pike
PhD
- Lecturer in Immunology, Harvard Medical School
- Curriculum Fellow in Online Learning
Keith Flaherty, MD, Professor of Medicine, Harvard Medical School / Hematologist/ Oncologist, Massachusetts General Hospital
Gordon Freeman, PhD, Professor of Medicine, Harvard Medical School
Timothy Graubert, MD, Professor of Medicine, Harvard Medical School / Hematologist/Oncologist, Massachusetts General Hospital
F. Stephen Hodi, MD, Professor of Medicine, Harvard Medical School / Medical Oncologist, Dana-Farber Cancer Institute
Marcela Maus, MD, PhD, Assistant Professor of Medicine, Harvard Medical School / Hematologist/Oncologist, Massachusetts General Hospital
Nikhil C. Munshi, MD, Professor of Medicine, Harvard Medical School / Medical Oncologist, Dana-Farber Cancer Institute
Lynette Sholl, MD, Associate Professor of Pathology, Harvard Medical School / Pathologist, Brigham and Women’s Hospital
Scott Rodig, MD, PhD, Associate Professor of Pathology, Harvard Medical School / Pathologist, Dana-Farber Cancer Institute
Arlene Sharpe, MD, PhD, Kolokotrones University Professor, Harvard Medical School / Chair of the Department of Immunology and Director of the Mouse Engineering Core, Harvard Medical School
Course Quiz
Are you ready for an advanced course? We recommend knowledge of basic chemistry, biology, and physics, as well as knowledge of key immunology concepts. Gauge your knowledge of immunology by taking this short quiz.
From Our Learners
Hear from HMX students as they share their experiences learning online with Harvard Medical School.
"[This course] provides a really strong foundation to be able to very much lean into the future in terms of the developments of immuno-oncology."
Request Information
Interested in learning more about this program? Sign up for details.